Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stanton

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Biorxiv : the Preprint Server for Biology|September 26, 2025
Vascular-Perfusable Human 3D Brain-on-ChipAlice E Stanton, Rebecca L Pinals, Aaron Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2025
Engineered 3D immuno-glial-neurovascular human miBrain modelAlice E Stanton, Adele Bubnys, Emre Agbas, et al.
Journal for Immunotherapy of Cancer|September 17, 2021
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlatesJohn B Liao, William R Gwin, Renata R Urban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2019
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Clare J Twist, Mary Lou Schmidt, Arlene Naranjo, et al.
Journal of Pediatric Surgery|September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Erin G Brown, E Stanton Adkins, Peter Mattei, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Cancer Medicine|January 16, 2023
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effectsZev M Nakamura, Allison M Deal, Eliza M Park, et al.
Annals of the New York Academy of Sciences|September 30, 2022
Engineering multicellular living systems-a Keystone Symposia reportJennifer Cable, Paola Arlotta, Kevin Kit Parker, et al.
American Journal of Respiratory and Critical Care Medicine|September 20, 2017
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural EffusionEleanor K Mishra, Amelia O Clive, Genevieve H Wills, et al.
The New England Journal of Medicine|April 5, 2018
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant EffusionRahul Bhatnagar, Emma K Keenan, Anna J Morley, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Biorxiv : the Preprint Server for Biology|September 26, 2025
Vascular-Perfusable Human 3D Brain-on-ChipAlice E Stanton, Rebecca L Pinals, Aaron Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2025
Engineered 3D immuno-glial-neurovascular human miBrain modelAlice E Stanton, Adele Bubnys, Emre Agbas, et al.
Journal for Immunotherapy of Cancer|September 17, 2021
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlatesJohn B Liao, William R Gwin, Renata R Urban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2019
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Clare J Twist, Mary Lou Schmidt, Arlene Naranjo, et al.
Journal of Pediatric Surgery|September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Erin G Brown, E Stanton Adkins, Peter Mattei, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Cancer Medicine|January 16, 2023
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effectsZev M Nakamura, Allison M Deal, Eliza M Park, et al.
Annals of the New York Academy of Sciences|September 30, 2022
Engineering multicellular living systems-a Keystone Symposia reportJennifer Cable, Paola Arlotta, Kevin Kit Parker, et al.
American Journal of Respiratory and Critical Care Medicine|September 20, 2017
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural EffusionEleanor K Mishra, Amelia O Clive, Genevieve H Wills, et al.
The New England Journal of Medicine|April 5, 2018
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant EffusionRahul Bhatnagar, Emma K Keenan, Anna J Morley, et al.
Pageof 36